American Medical Systems Holdings, Inc. develops and delivers medical technology solutions to physicians treating men’s and women’s pelvic health conditions. The company offers surgical products to urologists, gynecologists, and urogynecologists for erectile restoration, benign prostatic hyperplasia, male urethral stricture, urinary and fecal incontinence, and pelvic floor repair. Its products for men include AMS 800, an urinary sphincter product; InVance sling system, a procedure for men with moderate incontinence; AdVance sling system for the treatment of mild to moderate stress urinary incontinence; UroLume endoprosthesis stent for men suffering from bulbar urethral strictures; Acticon Ne...
10700 Bren Road West
Minnetonka, MN 55343
Founded in 1972
Bernstein Liebhard LLP Notes New Order Dismissing Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., American Medical Systems Holdings Inc. as Defendants in Federal Vaginal Mesh Litigations
Apr 14 13
Bernstein Liebhard LLP reported that thousands of transvaginal mesh lawsuits continue to proceed in multidistrict litigations underway in U.S. District Court, Southern District of West Virginia. According to a joint Pretrial Order dated April 3, 2013, Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., and American Medical Systems Holdings Inc. (Endo Entities) have been dismissed as Defendants, per an agreement between the Endo Entities, Defendant American Medical Systems, Inc., and Plaintiffs' attorneys. The Order applies to all of the vaginal mesh lawsuits filed in the Southern District of West Virginia, including those pending in re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2325); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2187); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2327). Bernstein Liebhard LLP partner, Jeffrey S. Grand, serves on the Plaintiffs' Steering Committee in all four of these proceedings. The litigation surrounding vaginal mesh has been growing since 2011, when the U.S. Food & Drug Administration (FDA) warned that there had been a five-fold increase in reports of serious transvaginal mesh complications, including mesh erosion through vaginal tissue, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence. The FDA also modified its previous position on the frequency of such complications, stating in the alert that vaginal mesh injuriesassociated with pelvic organ prolapse repair were not rare. In January 2012, the agency ordered the manufacturers of vaginal mesh devicesused in prolapse repair to conduct post-market safety studies as part of its review. In addition to the vaginal mesh lawsuits pending in the federal multidistrict litigations, thousands of additional claims involving Ethicon and C.R. Bard products are also pending in two consolidated proceedings underway in Atlantic County Superior Court, New Jersey. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10). Bernstein Liebhard LLP partner, Jeffrey Grand is serving as Co-Liaison Counsel in both of these litigations. Earlier this month, the nation's first trial involving an Ethicon mesh product concluded in New Jersey state court, with the jury awarding more than $11 million in compensatory and punitive damages tothe Plaintiff. Mr. Grand also served on the Plaintiff's trial team. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City)). Victims of alleged vaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries.